Clinical Trial

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

Study acronym: POAG
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Trial Details
NCT Number NCT07228221
Lead Sponsor Jonathon Myers
Collaborators: Glaukos Corporation
Conditions Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma
Enrollment 20 participants
Start Date 2026-01-05
Primary Completion 2031-08-30 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-14